Robin L. Washington
2017
In 2017, Robin L. Washington earned a total compensation of $5.5M as Executive Vice President and Chief Financial Officer at Gilead Sciences, a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,152,600 |
|---|---|
| Option Awards | $1,800,015 |
| Salary | $953,231 |
| Stock Awards | $1,613,500 |
| Other | $10,000 |
| Total | $5,529,346 |
Washington received $1.8M in option awards, accounting for 33% of the total pay in 2017.
Washington also received $1.2M in non-equity incentive plan, $953.2K in salary, $1.6M in stock awards and $10K in other compensation.
Rankings
In 2017, Robin L. Washington's compensation ranked 1,643rd out of 14,666 executives tracked by ExecPay. In other words, Washington earned more than 88.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,643 out of 14,666 | 89th |
Division Manufacturing | 553 out of 5,772 | 90th |
Major group Chemicals And Allied Products | 146 out of 2,075 | 93rd |
Industry group Drugs | 106 out of 1,731 | 94th |
Industry Biological Products, Except Diagnostic Substances | 20 out of 313 | 94th |
Source: SEC filing on March 26, 2018.
Washington's colleagues
We found five more compensation records of executives who worked with Robin L. Washington at Gilead Sciences in 2017.